EVE Health GroupASX:EVE Return-on-Tangible-Equity is -256.58% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 1,872 Consumer Packaged Goods companies, EVE Health Group ranks worse than 99.04% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. EVE Health Group's annualized net income for the quarter that ended in Dec. 2025 was A$-1.70 Mil. EVE Health Group's average shareholder tangible equity for the quarter that ended in Dec. 2025 was A$0.66 Mil. Therefore, EVE Health Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was -256.58%.
The historical rank and industry rank for EVE Health Group's Return-on-Tangible-Equity or its related term are showing as below:
ASX:EVE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -279.64 Med: -53.23 Max: -28.37
Current: -279.64
During the past 13 years, EVE Health Group's highest Return-on-Tangible-Equity was -28.37%. The lowest was -279.64%. And the median was -53.23%.
ASX:EVE's Return-on-Tangible-Equity is ranked worse than 99.04% of 1872
companies
in the Consumer Packaged Goods industry
Industry Median: 7.73
vs ASX:EVE: -279.64
EVE Health Group (ASX:EVE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
EVE Health Group Return-on-Tangible-Equity Related Terms
EVE Health Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for EVE Health Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EVE vs KHC, GIS: Return-on-Tangible-Equity Comparison
For the Packaged Foods subindustry, EVE Health Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where EVE Health Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -256.58% mean?
EVE Health Group (ASX:EVE) has a Return-on-Tangible-Equity of -256.58% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #1854 out of 1872 companies in the Consumer Packaged Goods industry, placing it in the top 99%.
Is EVE Health Group's Return-on-Tangible-Equity too high?
EVE Health Group's current Return-on-Tangible-Equity is -256.58%. Based on the distribution chart, EVE Health Group ranks #1854 out of 1872 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's Return-on-Tangible-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #1854 out of 1872 companies for Return-on-Tangible-Equity. This places EVE Health Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.73, based on 1,872 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current Return-on-Tangible-Equity is -256.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current Return-on-Tangible-Equity is -256.58%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current Return-on-Tangible-Equity is -256.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 